{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:19:32Z","timestamp":1790965172776,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70464-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:07:22Z","timestamp":1773709642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A highly potent nanobody-based bispecific therapeutic provides broad-spectrum protection against ebolavirus"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8860-3329","authenticated-orcid":false,"given":"Meihua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-8590","authenticated-orcid":false,"given":"Yanfeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Entao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2240-7870","authenticated-orcid":false,"given":"Jinge","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8264-7523","authenticated-orcid":false,"given":"Peng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1395-188X","authenticated-orcid":false,"given":"Tengchuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-5755","authenticated-orcid":false,"given":"Sandra","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"70464_CR1","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1128\/JVI.03118-12","volume":"87","author":"SA Carroll","year":"2013","unstructured":"Carroll, S. A. et al. Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences. J. Virol. 87, 2608\u20132616 (2013).","journal-title":"J. Virol."},{"key":"70464_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev-virology-092818-015708","volume":"6","author":"W Furuyama","year":"2019","unstructured":"Furuyama, W. & Marzi, A. Ebola virus: pathogenesis and countermeasure development. Ann. Rev. Virol. 6, 435\u2013458 (2019).","journal-title":"Ann. Rev. Virol."},{"key":"70464_CR3","doi-asserted-by":"crossref","unstructured":"Jain, S., Martynova, E., Rizvanov, A., Khaiboullina, S. & Baranwal, M. Structural and functional aspects of Ebola virus proteins. Pathogens 10, 1330 (2021).","DOI":"10.3390\/pathogens10101330"},{"key":"70464_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/14760584.2020.1738225","volume":"19","author":"K O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell, K. & Marzi, A. The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms. Expert Rev. Vaccines 19, 267\u2013277 (2020).","journal-title":"Expert Rev. Vaccines"},{"key":"70464_CR5","doi-asserted-by":"publisher","first-page":"e0006349","DOI":"10.1371\/journal.pntd.0006349","volume":"12","author":"D Cantoni","year":"2018","unstructured":"Cantoni, D. & Rossman, J. S. Ebolaviruses: New roles for old proteins. PLoS Negl. Trop. Dis. 12, e0006349 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"70464_CR6","doi-asserted-by":"publisher","first-page":"5762","DOI":"10.1073\/pnas.95.10.5762","volume":"95","author":"VE Volchkov","year":"1998","unstructured":"Volchkov, V. E., Feldmann, H., Volchkova, V. A. & Klenk, H. D. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. USA 95, 5762\u20135767 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70464_CR7","doi-asserted-by":"publisher","first-page":"12463","DOI":"10.1128\/JVI.76.24.12463-12472.2002","volume":"76","author":"SA Jeffers","year":"2002","unstructured":"Jeffers, S. A., Sanders, D. A. & Sanchez, A. Covalent modifications of the ebola virus glycoprotein. J. Virol. 76, 12463\u201312472 (2002).","journal-title":"J. Virol."},{"key":"70464_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nature18615","volume":"535","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. et al. Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature 535, 169\u2013172 (2016).","journal-title":"Nature"},{"key":"70464_CR9","doi-asserted-by":"publisher","first-page":"e00862","DOI":"10.1128\/mBio.00862-13","volume":"5","author":"NJ Lennemann","year":"2014","unstructured":"Lennemann, N. J. et al. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. mBio 5, e00862\u201300813 (2014).","journal-title":"mBio"},{"key":"70464_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fcimb.2020.00048","volume":"10","author":"M Iraqi","year":"2020","unstructured":"Iraqi, M. et al. N-Glycans mediate the Ebola virus-GP1 shielding of ligands to immune receptors and immune evasion. Front. Cell Infect. Microbiol. 10, 48 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"70464_CR11","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1110656","volume":"308","author":"K Chandran","year":"2005","unstructured":"Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P. & Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643\u20131645 (2005).","journal-title":"Science"},{"key":"70464_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2015.12.044","volume":"164","author":"H Wang","year":"2016","unstructured":"Wang, H. et al. Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell 164, 258\u2013268 (2016).","journal-title":"Cell"},{"key":"70464_CR13","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.cell.2016.05.022","volume":"165","author":"X Gong","year":"2016","unstructured":"Gong, X. et al. Structural insights into the Niemann-Pick C1 (NPC1)-mediated cholesterol transfer and Ebola infection. Cell 165, 1467\u20131478 (2016).","journal-title":"Cell"},{"key":"70464_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1097-2765(00)80159-8","volume":"2","author":"W Weissenhorn","year":"1998","unstructured":"Weissenhorn, W., Carf\u00ed, A., Lee, K. H., Skehel, J. J. & Wiley, D. C. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell 2, 605\u2013616 (1998).","journal-title":"Mol. Cell"},{"key":"70464_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature07082","volume":"454","author":"JE Lee","year":"2008","unstructured":"Lee, J. E. et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177\u2013182 (2008).","journal-title":"Nature"},{"key":"70464_CR16","doi-asserted-by":"publisher","first-page":"11211","DOI":"10.1073\/pnas.1104760108","volume":"108","author":"SM Gregory","year":"2011","unstructured":"Gregory, S. M. et al. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc. Natl. Acad. Sci. USA 108, 11211\u201311216 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70464_CR17","doi-asserted-by":"publisher","first-page":"E7987","DOI":"10.1073\/pnas.1708052114","volume":"114","author":"J Lee","year":"2017","unstructured":"Lee, J. et al. Structure of the Ebola virus envelope protein MPER\/TM domain and its interaction with the fusion loop explains their fusion activity. Proc. Natl. Acad. Sci. USA 114, E7987\u2013e7996 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70464_CR18","doi-asserted-by":"crossref","unstructured":"Coltart, C. E., Lindsey, B., Ghinai, I., Johnson, A. M. & Heymann, D. L. The Ebola outbreak, 2013-2016: old lessons for new epidemics. Philo. Trans. R. Soc. London. Ser. B Biol. Sci. 372, 20160297 (2017).","DOI":"10.1098\/rstb.2016.0297"},{"key":"70464_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature13777","volume":"514","author":"X Qiu","year":"2014","unstructured":"Qiu, X. et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 514, 47\u201353 (2014).","journal-title":"Nature"},{"key":"70464_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40265-020-01452-3","volume":"81","author":"A Markham","year":"2021","unstructured":"Markham, A. REGN-EB3: first approval. Drugs 81, 175\u2013178 (2021).","journal-title":"Drugs"},{"key":"70464_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chom.2023.01.002","volume":"31","author":"V Rayaprolu","year":"2023","unstructured":"Rayaprolu, V. et al. Structure of the Inmazeb cocktail and resistance to Ebola virus escape. Cell Host Microbe 31, 260\u2013272.e267 (2023).","journal-title":"Cell Host Microbe"},{"key":"70464_CR22","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.aad6117","volume":"351","author":"J Misasi","year":"2016","unstructured":"Misasi, J. et al. Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science 351, 1343\u20131346 (2016).","journal-title":"Science"},{"key":"70464_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(19)30036-4","volume":"393","author":"MR Gaudinski","year":"2019","unstructured":"Gaudinski, M. R. et al. Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study. Lancet 393, 889\u2013898 (2019).","journal-title":"Lancet"},{"key":"70464_CR24","doi-asserted-by":"crossref","unstructured":"Ibrahim, S. K., Ndwandwe, D. E., Thomas, K., Sigfrid, L. & Norton, A. Sudan virus disease outbreak in Uganda: urgent research gaps. BMJ Global Health 7, e010982 (2022).","DOI":"10.1136\/bmjgh-2022-010982"},{"key":"70464_CR25","doi-asserted-by":"publisher","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","volume":"4","author":"JS Towner","year":"2008","unstructured":"Towner, J. S. et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. Plos Pathog. 4, e1000212 (2008).","journal-title":"Plos Pathog."},{"key":"70464_CR26","doi-asserted-by":"publisher","first-page":"e1012038","DOI":"10.1371\/journal.ppat.1012038","volume":"20","author":"LW El Ayoubi","year":"2024","unstructured":"El Ayoubi, L. W., Mahmoud, O., Zakhour, J. & Kanj, S. S. Recent advances in the treatment of Ebola disease: a brief overview. PLoS Pathog. 20, e1012038 (2024).","journal-title":"PLoS Pathog."},{"key":"70464_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1083429","volume":"14","author":"E Taki","year":"2023","unstructured":"Taki, E. et al. Ebanga\u2122: the most recent FDA-approved drug for treating Ebola. Front. Pharmacol. 14, 1083429 (2023).","journal-title":"Front. Pharmacol."},{"key":"70464_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.sbi.2016.10.019","volume":"45","author":"D K\u00f6nning","year":"2017","unstructured":"K\u00f6nning, D. et al. Camelid and shark single domain antibodies: structural features and therapeutic potential. Curr. Opin. Struct. Biol. 45, 10\u201316 (2017).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"70464_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tibtech.2014.03.001","volume":"32","author":"T De Meyer","year":"2014","unstructured":"De Meyer, T., Muyldermans, S. & Depicker, A. Nanobody-based products as research and diagnostic tools. Trends Biotechnol. 32, 263\u2013270 (2014).","journal-title":"Trends Biotechnol."},{"key":"70464_CR30","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1146\/annurev-biochem-063011-092449","volume":"82","author":"S Muyldermans","year":"2013","unstructured":"Muyldermans, S. Nanobodies: natural single-domain antibodies. Annu Rev. Biochem. 82, 775\u2013797 (2013).","journal-title":"Annu Rev. Biochem."},{"key":"70464_CR31","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.drudis.2016.04.003","volume":"21","author":"S Steeland","year":"2016","unstructured":"Steeland, S., Vandenbroucke, R. E. & Libert, C. Nanobodies as therapeutics: big opportunities for small antibodies. Drug Discov. Today 21, 1076\u20131113 (2016).","journal-title":"Drug Discov. Today"},{"key":"70464_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coviro.2012.02.015","volume":"2","author":"EH Miller","year":"2012","unstructured":"Miller, E. H. & Chandran, K. Filovirus entry into cells - new insights. Curr. Opin. Virol. 2, 206\u2013214 (2012).","journal-title":"Curr. Opin. Virol."},{"key":"70464_CR33","doi-asserted-by":"publisher","first-page":"e1004731","DOI":"10.1371\/journal.ppat.1004731","volume":"11","author":"S Moller-Tank","year":"2015","unstructured":"Moller-Tank, S. & Maury, W. Ebola virus entry: a curious and complex series of events. Plos Pathog. 11, e1004731 (2015).","journal-title":"Plos Pathog."},{"key":"70464_CR34","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1128\/JVI.80.8.4174-4178.2006","volume":"80","author":"K Schornberg","year":"2006","unstructured":"Schornberg, K. et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174\u20134178 (2006).","journal-title":"J. Virol."},{"key":"70464_CR35","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature10380","volume":"477","author":"M C\u00f4t\u00e9","year":"2011","unstructured":"C\u00f4t\u00e9, M. et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477, 344\u2013348 (2011).","journal-title":"Nature"},{"key":"70464_CR36","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"JE Carette","year":"2011","unstructured":"Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340\u2013343 (2011).","journal-title":"Nature"},{"key":"70464_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1128\/JVI.01828-15","volume":"90","author":"JA Simmons","year":"2016","unstructured":"Simmons, J. A. et al. Ebolavirus glycoprotein directs fusion through NPC1+ endolysosomes. J. Virol. 90, 605\u2013610 (2016).","journal-title":"J. Virol."},{"key":"70464_CR38","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1128\/JVI.05708-11","volume":"86","author":"M Brecher","year":"2012","unstructured":"Brecher, M. et al. Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change. J. Virol. 86, 364\u2013372 (2012).","journal-title":"J. Virol."},{"key":"70464_CR39","doi-asserted-by":"publisher","first-page":"e01857","DOI":"10.1128\/mBio.01857-15","volume":"7","author":"JS Spence","year":"2016","unstructured":"Spence, J. S., Krause, T. B., Mittler, E., Jangra, R. K. & Chandran, K. Direct visualization of Ebola virus fusion triggering in the endocytic pathway. mBio 7, e01857\u201301815 (2016).","journal-title":"mBio"},{"key":"70464_CR40","doi-asserted-by":"crossref","unstructured":"Mittler, E., Alkutkar, T., Jangra, R. K. & Chandran, K. Direct Intracellular visualization of Ebola Virus-receptor interaction by in situ proximity ligation. mBio 12 10\u20131128 (2021).","DOI":"10.1128\/mBio.03100-20"},{"key":"70464_CR41","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1016\/j.cell.2021.09.035","volume":"184","author":"P Gilchuk","year":"2021","unstructured":"Gilchuk, P. et al. Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell 184, 5593\u20135607.e5518 (2021).","journal-title":"Cell"},{"key":"70464_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.immuni.2018.06.018","volume":"49","author":"P Gilchuk","year":"2018","unstructured":"Gilchuk, P. et al. Multifunctional pan-ebolavirus antibody recognizes a site of broad vulnerability on the ebolavirus glycoprotein. Immunity 49, 363\u2013374.e310 (2018).","journal-title":"Immunity"},{"key":"70464_CR43","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cell.2022.02.023","volume":"185","author":"JC Milligan","year":"2022","unstructured":"Milligan, J. C. et al. Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses. Cell 185, 995\u20131007.e1018 (2022).","journal-title":"Cell"},{"key":"70464_CR44","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cell.2017.04.037","volume":"169","author":"AZ Wec","year":"2017","unstructured":"Wec, A. Z. et al. Antibodies from a human survivor define sites of vulnerability for broad protection against Ebolaviruses. Cell 169, 878\u2013890.e815 (2017).","journal-title":"Cell"},{"key":"70464_CR45","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.aad5788","volume":"351","author":"ZA Bornholdt","year":"2016","unstructured":"Bornholdt, Z. A. et al. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science 351, 1078\u20131083 (2016).","journal-title":"Science"},{"key":"70464_CR46","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2017.04.038","volume":"169","author":"X Zhao","year":"2017","unstructured":"Zhao, X. et al. Immunization-elicited broadly protective antibody reveals ebolavirus fusion loop as a site of vulnerability. Cell 169, 891\u2013904.e815 (2017).","journal-title":"Cell"},{"key":"70464_CR47","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1128\/JVI.01956-08","volume":"83","author":"D Dube","year":"2009","unstructured":"Dube, D. et al. The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J. Virol. 83, 2883\u20132891 (2009).","journal-title":"J. Virol."},{"key":"70464_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41586-025-09265-8","volume":"645","author":"M Oosterlaken","year":"2025","unstructured":"Oosterlaken, M. et al. Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction. Nature 645, 262\u2013270 (2025).","journal-title":"Nature"},{"key":"70464_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"70464_CR50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"70464_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jsb.2015.08.007","volume":"192","author":"JL Rubinstein","year":"2015","unstructured":"Rubinstein, J. L. & Brubaker, M. A. Alignment of cryo-EM movies of individual particles by optimization of image translations. J. Struct. Biol. 192, 188\u2013195 (2015).","journal-title":"J. Struct. Biol."},{"key":"70464_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"70464_CR53","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.str.2008.03.005","volume":"16","author":"LG Trabuco","year":"2008","unstructured":"Trabuco, L. G., Villa, E., Mitra, K., Frank, J. & Schulten, K. Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. Structure 16, 673\u2013683 (2008).","journal-title":"Structure"},{"key":"70464_CR54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. Sect. D. Biol. Crystallogr. 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. Sect. D. Biol. Crystallogr."},{"key":"70464_CR55","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr. 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr."},{"key":"70464_CR56","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"70464_CR57","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"70464_CR58","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1016\/j.cell.2021.06.002","volume":"184","author":"R Copin","year":"2021","unstructured":"Copin, R. et al. The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies. Cell 184, 3949\u20133961.e3911 (2021).","journal-title":"Cell"},{"key":"70464_CR59","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1126\/science.abd0831","volume":"369","author":"A Baum","year":"2020","unstructured":"Baum, A. et al. Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science 369, 1014\u20131018 (2020).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70464-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70464-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70464-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T20:02:32Z","timestamp":1778011352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70464-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70464"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70464-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.C.T., M.H.W., S.C., and E.T.L. are named inventors on two patents covering the sequences of the 1A10 and BA2 nanobodies described in this study. These patents pertain to the use of said nanobodies for the prevention, treatment, or diagnosis of Ebola virus infection and impose no restrictions on data publication. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4040"}}